Trial intelligence / Profile preview

ZX008 (fenfluramine) in Lennox-Gastaut syndrome – randomized trial with open-label extension

jRCT2041200096Completed

Sponsor
UCB
Start
May 2019
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of fenfluramine in Lennox-Gastaut syndrome (LGS) (4 arms), sponsored by UCB. Started May 2019; status: completed.

02

Drugs

fenfluramine
03

Conditions

Lennox-Gastaut syndrome (LGS)

Beyond the preview

Go deeper on jRCT2041200096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2041200096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call